Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study (Q77766244)
Jump to navigation
Jump to search
scientific article published on 01 May 1999
Language | Label | Description | Also known as |
---|---|---|---|
English | Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study |
scientific article published on 01 May 1999 |
Statements
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study (English)
L F van den Merkhof
H Olsson
L Grip
G Veen
F W Bär
M J van den Brand
M L Simoons